i3 Prism

i3 Prism aims to foster innovators and innovations that have not been previously awarded significant funding, to expand the pool of early-stage health care solutions in Mount Sinai’s commercialization pipeline. Selected applicants will receive up to $33K in funding, which will be distributed based on the achievement of milestones.

Innovators seeking to develop their technology with the potential for commercialization can submit to the i3 Prism Request for Proposals (RFP) during the proposal period. Applicants must also disclose the technology to MSIP. The submitted proposals will be distributed for review among Mount Sinai experts in fields including medical devices, digital health, and therapeutics. Applications will be judged and scored based on project feasibility and market risks against the budget and milestones provided. Recorded scores from the reviewers will be pulled and tabulated by members of an internal working group and the awardees will be selected. When the awardees are notified and have signed an Informed Participation Letter (IPL), fund accounts will be created and funding will be disbursed.

Are you interested in being considered for i3 Prism and have not disclosed the technology? Disclose here.

Eligible applicants must:

Proposals involving Human Subjects or Animal Research may require extra steps, such as gaining formal approval from the Institutional Review Board (IRB) or the Institutional Animal Care and Use Committee (IACUC).

The RFP period for 2025 is now open! Submit your proposal by Monday, March 17.

If you have any questions, please contact Cynthia Cleto, MS, Senior Director of Outreach, Entrepreneurship and Special Programs at cynthia.cleto@mssm.edu and Steffanie Haripersaud, MHA, Program Manager, at steffanie.haripersaud@mssm.edu.